publicMHRA · United Kingdom · Updated Aug 17, 2026
MHRA Launches 14-Day Pilot Programme for Phase 1 Clinical Trials
Sponsors of Phase 1 trials must review the eligibility criteria for the 14-day pilot and ensure their internal clinical safety and regulatory teams prepare high-quality 'low-risk' clinical trial application packs to comply with the new assessment timeline.
Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Guideline / Pilot Notice
Read impact briefarrow_forward